RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19535499http://www.w3.org/2000/01/rdf-schema#comment"Examination of embryonic myogenesis of two distinct, but functionally related, skeletal muscle dystrophy mutants (mdx and cav-3(-/-)) establishes for the first time that key elements of the pathology of Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophy type 1C (LGMD-1c) originate in the disruption of the embryonic cardiac and skeletal muscle patterning processes. Disruption of myogenesis occurs earlier in mdx mutants, which lack a functional form of dystrophin, than in cav-3(-/-) mutants, which lack the Cav3 gene that encodes the protein caveolin-3; this finding is consistent with the milder phenotype of LGMD-1c, a condition caused by mutations in Cav3, and the earlier [embryonic day (E)9.5] expression of dystrophin. Myogenesis is severely disrupted in mdx embryos, which display developmental delays; myotube morphology and displacement defects; and aberrant stem cell behaviour. In addition, the caveolin-3 protein is elevated in mdx embryos. Both cav-3(-/-) and mdx mutants (from E15.5 and E11.5, respectively) exhibit hyperproliferation and apoptosis of Myf5-positive embryonic myoblasts; attrition of Pax7-positive myoblasts in situ; and depletion of total Pax7 protein in late gestation. Furthermore, both cav-3(-/-) and mdx mutants have cardiac defects. In cav-3(-/-) mutants, there is a more restricted phenotype comprising hypaxial muscle defects, an excess of malformed hypertrophic myotubes, a twofold increase in myonuclei, and reduced fast myosin heavy chain (FMyHC) content. Several mdx mutant embryo pathologies, including myotube hypotrophy, reduced myotube numbers and increased FMyHC, have reciprocity with cav-3(-/-) mutants. In double mutant (mdxcav-3(+/-)) embryos that are deficient in dystrophin (mdx) and heterozygous for caveolin-3 (cav-3(+/-)), whereby caveolin-3 is reduced to 50% of wild-type (WT) levels, these phenotypes are severely exacerbated: intercostal muscle fibre density is reduced by 71%, and Pax7-positive cells are depleted entirely from the lower limbs and severely attenuated elsewhere; these data suggest a compensatory rather than a contributory role for the elevated caveolin-3 levels that are found in mdx embryos. These data establish a key role for dystrophin in early muscle formation and demonstrate that caveolin-3 and dystrophin are essential for correct fibre-type specification and emergent stem cell function. These data plug a significant gap in the natural history of muscular dystrophy and will be invaluable in establishing an earlier diagnosis for DMD/LGMD and in designing earlier treatment protocols, leading to better clinical outcome for these patients."xsd:string
http://purl.uniprot.org/citations/19535499http://purl.org/dc/terms/identifier"doi:10.1242/dmm.001008"xsd:string
http://purl.uniprot.org/citations/19535499http://purl.uniprot.org/core/author"Smith J."xsd:string
http://purl.uniprot.org/citations/19535499http://purl.uniprot.org/core/author"Merrick D."xsd:string
http://purl.uniprot.org/citations/19535499http://purl.uniprot.org/core/author"Stadler L.K."xsd:string
http://purl.uniprot.org/citations/19535499http://purl.uniprot.org/core/author"Larner D."xsd:string
http://purl.uniprot.org/citations/19535499http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/19535499http://purl.uniprot.org/core/name"Dis Model Mech"xsd:string
http://purl.uniprot.org/citations/19535499http://purl.uniprot.org/core/pages"374-388"xsd:string
http://purl.uniprot.org/citations/19535499http://purl.uniprot.org/core/title"Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation."xsd:string
http://purl.uniprot.org/citations/19535499http://purl.uniprot.org/core/volume"2"xsd:string
http://purl.uniprot.org/citations/19535499http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19535499
http://purl.uniprot.org/citations/19535499http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/19535499
http://purl.uniprot.org/uniprot/P51637#attribution-413B6431C4E509C0C4611DA334866523http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/P11531#attribution-413B6431C4E509C0C4611DA334866523http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/#_A0A023ZT56-mappedCitation-19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/#_A0A023ZTV5-mappedCitation-19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/#_A0A1Q1NN66-mappedCitation-19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/#_A0A1Q1PRS2-mappedCitation-19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/#_A0A1Q1PRS4-mappedCitation-19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/#_A0A1Q1PRS6-mappedCitation-19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/#_A0A1Q1PRS9-mappedCitation-19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/#_A0A1Q1PRT9-mappedCitation-19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535499
http://purl.uniprot.org/uniprot/#_A2A9Z1-mappedCitation-19535499http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535499